GlassScriptPhysician profile
Manjit S Bhamrah
NPI 1699706341
$12,322.96
in general payments reported to CMS, 2019-2025
55 companies · $2,696 in 2025
The $2,696 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,466 · 2020: $1,126 · 2021: $1,312 · 2022: $1,888 · 2023: $1,610 · 2024: $2,225 · 2025: $2,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,350 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,350.45 |
| Education | $180.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,914.60 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,667.37 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Astrazeneca Pharmaceuticals LP | $1,563.57 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Mylan Specialty L.P. | $813.25 | 2019-2024 | Yupelri |
| Genzyme Corporation | $775.99 | 2021-2025 | |
| Electromed, INC. | $617.88 | 2019-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $573.86 | 2020-2025 | Glassia |
| Philips North America LLC | $472.17 | 2019-2025 | Vest Therapy Und, (Ad1) Nasal Masks - Traditional, (6299) Dreamwear |
| Insmed, INC. | $343.05 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $257.97 | 2019-2025 | Dupixent |
| Harmony Biosciences LLC | $241.60 | 2021-2024 | |
| Inspire Medical Systems, INC. | $224.35 | 2023-2025 | Inspire |
| Fisher & Paykel Healthcare INC | $197.80 | 2023-2025 | Fisher & Paykel Healthcare |
| Intuitive Surgical, INC. | $159.21 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $146.10 | 2019-2025 | Opsumit, Uptravi |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noah Medical Corporation | $142.38 | 2025 | Galaxy |
| Inogen, INC. | $141.81 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Jazz Pharmaceuticals INC. | $137.48 | 2019-2025 | |
| Phadia US INC. | $113.14 | 2020-2024 | Immunocap |
| Baxter Healthcare | $108.94 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Axsome Therapeutics, INC. | $107.25 | 2024 | Sunosi |
| Covidien LP | $103.05 | 2019 | |
| Mallinckrodt Hospital Products INC. | $98.45 | 2021-2022 | |
| Verona Pharma, INC. | $91.84 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $85.82 | 2025 | Yupelri |
| Genentech USA, INC. | $83.27 | 2022-2025 | Xolair |
| Sanofi-Aventis U.S. LLC | $79.99 | 2024 | |
| Aerin Medical INC. | $78.17 | 2020 | |
| United Therapeutics Corporation | $71.78 | 2022-2025 | Tyvaso, Tyvaso |
| Covis Pharma Gmbh | $67.24 | 2022 | |
| Advanced Respiratory, INC | $63.94 | 2020-2021 | |
| Amgen INC. | $61.06 | 2022-2025 | Tezspire, Tavneos |
| Sunovion Pharmaceuticals INC. | $60.74 | 2019-2020 | |
| Biogen, INC. | $58.41 | 2023-2024 | Spinraza |
| Abbott Laboratories | $55.60 | 2019-2020 | |
| Circassia INC. | $51.85 | 2019-2020 | |
| Lilly USA, LLC | $46.06 | 2025 | Zepbound |
| Pulmonx Corporation | $44.56 | 2019-2024 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Zoll Respicardia, INC. | $43.48 | 2023-2024 | Remede System |
| Avadel Cns Pharmaceuticals, LLC | $42.68 | 2024-2025 | Lumryz |
| Shire North American Group INC | $40.51 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $32.78 | 2021 | |
| Gilead Sciences, INC. | $30.90 | 2023 | Veklury |
| Idorsia Pharmaceuticals US INC | $28.06 | 2023 | Quviviq |
| Grifols USA, LLC | $23.72 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.68 | 2023 | |
| Mayne Pharma Commercial LLC | $19.74 | 2020 | |
| Merck Sharp & Dohme LLC | $16.97 | 2023 | Belsomra |
| Allergan, INC. | $16.81 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.69 | 2019 | |
| Optinose US, INC. | $15.82 | 2024 | |
| Paratek Pharmaceuticals, INC. | $15.47 | 2020 | |
| Shionogi INC | $14.74 | 2025 | Fetroja |
| Noctrix Health, INC. | $14.32 | 2025 | Nidra |
| Itamar Medical INC | $5.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manjit Bhamrah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.